341 related articles for article (PubMed ID: 37025585)
1. Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer.
Taheri M; Badrlou E; Hussen BM; Kashi AH; Ghafouri-Fard S; Baniahmad A
Front Oncol; 2023; 13():1123101. PubMed ID: 37025585
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
Momtazmanesh S; Rezaei N
Front Oncol; 2021; 11():712786. PubMed ID: 34322395
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs: From disease code to drug role.
Chen Y; Li Z; Chen X; Zhang S
Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA in prostate cancer.
An C; Wang I; Li X; Xia R; Deng F
Am J Clin Exp Urol; 2022; 10(3):170-179. PubMed ID: 35874287
[TBL] [Abstract][Full Text] [Related]
5. Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review.
Asemi R; Rajabpoor Nikoo N; Asemi Z; Shafabakhsh R; Hajijafari M; Sharifi M; Homayoonfal M; Davoodvandi A; Hakamifard A
Pathol Res Pract; 2023 Jun; 246():154507. PubMed ID: 37196467
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
7. Biological Function of Long Non-coding RNA (LncRNA) Xist.
Wang W; Min L; Qiu X; Wu X; Liu C; Ma J; Zhang D; Zhu L
Front Cell Dev Biol; 2021; 9():645647. PubMed ID: 34178980
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.
Roohinejad Z; Bahramian S; Shamsabadi FT; Sahebi R; Amini A; Sabour D; Shafiee M
BMC Cancer; 2023 Jan; 23(1):34. PubMed ID: 36624401
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNAs Profiling Using Microarray in Papillary Thyroid Carcinoma.
Islam F; Zhou Y; Lam AK
Methods Mol Biol; 2022; 2534():135-148. PubMed ID: 35670973
[TBL] [Abstract][Full Text] [Related]
11. Roles of lncRNA MAGI2-AS3 in human cancers.
Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract][Full Text] [Related]
13. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
[TBL] [Abstract][Full Text] [Related]
14. Emerging players in prostate cancer: long non-coding RNAs.
Sun T; Ye H; Wu CL; Lee GS; Kantoff PW
Am J Clin Exp Urol; 2014; 2(4):294-9. PubMed ID: 25606575
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma.
Ghafouri-Fard S; Gholipour M; Hussen BM; Taheri M
Front Oncol; 2021; 11():649107. PubMed ID: 33968749
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer.
Kumar S; Prajapati KS; Singh AK; Kushwaha PP; Shuaib M; Gupta S
Cancer Lett; 2021 Apr; 504():15-22. PubMed ID: 33556545
[TBL] [Abstract][Full Text] [Related]
17. The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.
Arriaga-Canon C; De La Rosa-Velázquez IA; González-Barrios R; Montiel-Manríquez R; Oliva-Rico D; Jiménez-Trejo F; Cortés-González C; Herrera LA
Oncotarget; 2018 Apr; 9(29):20872-20890. PubMed ID: 29755696
[TBL] [Abstract][Full Text] [Related]
18. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MAGI2-AS3 Inhibits Prostate Cancer Progression by Targeting the miR-142-3p.
Hu R; Wu P; Liu J
Horm Metab Res; 2022 Nov; 54(11):754-759. PubMed ID: 35944561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
